doi: 10.1016/S0140-6736(18)32261-X 13 GersteinHCColhounHMDagenaisGRDiazRLakshmananMPaisPet al
[5] The primary contraindication for hydroxocobalamin injection is a known hypersensitivity to hydroxocobalamin, cobalt, or any component of the formulation
The bottom line: Our findings suggest that GLP-1RA and SGLT2i (and especially SGLT2i with the lowest number needed to treat (NNT) for nearly all study outcomes) may be the preferred glucose-lowering agents for cardiovascular risk reduction in patients at moderate risk for CVD, building on and consistent with existing RCT evidence in the high-risk population. This report highlights potential preference for GLP-1 drugs as a first-line treatment for Type 2 diabetes related to its cardioprotective effect
For this reason, the product information displayed on the site may differ from the actual product you receive, so please be sure to check the product label and precautions of the product you receive before use
70% OFF today only link in comments
Risks can include diabetes, hypertension (high blood pressure), high cholesterol, sleep apnea, heart attack, stroke and even risks of early death